Yakushijin, Kimikazu http://orcid.org/0000-0003-2511-7857
Ikezoe, Takayuki
Ohwada, Chikako
Kudo, Kazuko
Okamura, Hiroshi
Goto, Hiroaki
Yabe, Hiromasa http://orcid.org/0000-0001-6508-5496
Yasumoto, Atsushi
Kuwabara, Hideyuki
Fujii, Shiro
Kagawa, Kumiko
Ogata, Masao http://orcid.org/0000-0002-4896-5878
Onishi, Yasushi
Kohno, Akio
Watamoto, Koichi
Uoshima, Nobuhiko
Nakamura, Daisuke
Ota, Shuichi
Ueda, Yasunori
Oyake, Tatsuo
Koike, Kazutoshi
Mizuno, Ishikazu
Iida, Hiroatsu
Katayama, Yoshio
Ago, Hiroatsu
Kato, Koji
Okamura, Atsuo
Kikuta, Atsushi
Fukuda, Takahiro
Article History
Received: 19 May 2018
Revised: 28 July 2018
Accepted: 30 July 2018
First Online: 20 August 2018
Compliance with ethical standards
:
: KY received honoraria from Asahi-kasei Pharma, JAZZ Pharmaceuticals, and Pfizer Inc. TI received grant/research support from Asahi-kasei Pharma. YU received research funding and travel expense fee from Kainos Laboratories Inc., Ablynx NV., and Eli Lilly Japan, outside submitted work. AK received grant/research support from JAZZ Pharmaceuticals and Nippon Shinyaku Co., Ltd. The remaining authors declare that they have no conflict of interest.